An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
Journal of Clinical Medicine · 10.11.2025 · 14 (22) · 7958
DOI: 10.3390/jcm14227958 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.11.2025. Verfasst von Pablo Balado-Simó und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, 08007 Barcelona, Spain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Galenicum.
Abstract (Originalsprache)
Topical tretinoin (all-trans-retinoic acid) is a first-generation vitamin A derivative with well-established efficacy in acne vulgaris and photoaging. Owing to its pleiotropic effects on epidermal differentiation, collagen synthesis, and skin pigmentation, numerous off-label uses have been proposed across dermatology. This narrative review summarizes current evidence on the efficacy and safety of topical tretinoin for multiple dermatological conditions, based on studies published between January 2000 and July 2025. Robust data from randomized clinical trials (RCTs) and systematic reviews support its benefit in acne and photoaging, whereas smaller RCTs and prospective studies indicate potential efficacy for melasma, postinflammatory hyperpigmentation, striae distensae, flat warts, alopecia areata, androgenetic alopecia, hypertrophic scars and keloids, and actinic keratosis and as pretreatment before chemical peels or laser resurfacing. However, high-quality, adequately powered trials with standardized outcome measures are still needed to establish clinical guidelines. Regarding cutaneous oncology, a large RCT demonstrated no preventive effect of tretinoin on keratinocyte carcinomas. Adverse events are typically mild, localized, and transient, and available evidence does not support an association with systemic adverse effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, 08007 Barcelona, Spain.
- Dermatology Department, Hospital de Figueras, Fundació Salut Empordà, 17600 Figueras, Spain.
- Clínica Corium Dermatology, 08007 Barcelona, Spain.
- Dermatology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
- Dermatology Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
ORCID-Profile: Pablo Balado-Simó, Sebastian Podlipnik
Förderung
- Galenicum
Zitieren
APA
Balado-Simó, P., Morgado-Carrasco, D., Gómez-Armayones, S., López-Ferrer, A., Barco, D., Ferrándiz-Pulido, C., & Podlipnik, S. (2025). An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer. Journal of Clinical Medicine, 14(22), 7958. https://doi.org/10.3390/jcm14227958
Vancouver
Balado-Simó P, Morgado-Carrasco D, Gómez-Armayones S, López-Ferrer A, Barco D, Ferrándiz-Pulido C, et al. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer. Journal of Clinical Medicine. 2025;14(22):7958. doi:10.3390/jcm14227958
BibTeX
@article{BaladoSim2025,
author = {Balado-Simó, Pablo and Morgado-Carrasco, Daniel and Gómez-Armayones, Sara and López-Ferrer, Anna and Barco, Didac and Ferrándiz-Pulido, Carla and Podlipnik, Sebastian},
title = {An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {22},
pages = {7958},
doi = {10.3390/jcm14227958}
}
EUVIMED